Just to be fair, a short position never has to cover as long as it is funded. This calculated risk assumes all stocks fall eventually, which NVIV has proven time and time again in the past. Unfortunately, when a paradigm shift in the fundamentals of the stock happens very quickly, the short position may reconsider its opportunity costs of the money invested. IMO, this is exactly what is transpiring. One small position closed friday. Others may follow before uplisting. When Invivo made it's intentions known about uplisting to Nasdaq/NYSE, institutions/hedges took notice. The paradigm of shorting this over the counter stock has changed. Once this stock goes Nasdaq, it opens itself up to mutal funds, retirement funds, institutional funds(who can't buy under 5/otc), swing traders, you get the picture. This company not only will have exclusive rights to the proceedures and applications for years to come, but more importantly, it possesses a product with an EMOTIONAL appeal. It would not be difficult to convince the institutional playters and mom/pop WHEN, and I say when, the media runs with this company's story via mainstream media on talk shows like Oprah, Dr OZ, Barrons, news outlets like CBS, print outlets like LA times and other outlets. In a nutshell, this story has real emotional appeal to the GENERAL population on a global scale, and that SELLS advertising, which in turn, promotes the company tor free to the masses. IMO, short covering will continue. In the past, NVIV was a decent short. Because of events outlined above, there are far better shorts out there than this stock now.
Amanda what part of "there are no shorts, because there is no appreciable short interest" do you not understand?
Shorts do not have to cover because there is no short interest. That means there are no investors that are currently short the stock. No investors being short the stock means there are no investors to cover a short position.
I believe you are well-intentioned; however, I doubt your actions are doing anything to help this stock. In fact, you seem to be the basher you are so concerned about.
1. You call people on this board "dumb."
2. You seem to want to frighten people into thinking shorts are in the process of driving the price down, when clearly there is no appreciable short interest - that is, there are no short positions in the retail market.
3. You seem to want to clutter the board with posts about Sybil, which for all we know could be YOU? Why divert attention from our company?
So, I ask you this question: How many of your posts are directed at nonexistent shorts, call other posters "Dumb" for handling their money the way they see fit, suggest "something is up," or are obsessed with a "short volume" statistic you neither understand nor wish to discuss with respect to the fact that there is no short interest. And how many of your posts are about the company?
Isn't the role of a basher to run people off by calling them "dumb," distract the board by getting posters worrying about boogeymen, get posters worried about loosing their money to evil shorts, and scare naive posters into thinking there is all kinds of "manipulation" going on?
Isn't that just what you do?
Why not just post about the positive for a while?
Sentiment: Strong Buy
Frank needs to be working on getting the company's name and mission out to the public. I mean major news outlets and not the local segments. Time to earn that salary that people are knocking you for, Frank!
Good thing that they are diminished but not gone. The shorts have also been our friends. Remember what happened after that idiot Springer article? It may not have been nice to see red in the accounts, but it did enable us to buy more long shares at reduced prices.
Sentiment: Strong Buy
Hi mix.jack, shorts indeed are a necessity. I bought in to NVIV(just a new baby here) at 1.66-1.78 for my core position(thank you, shorts), but bought more today and on other recent days as well. Another product that has the appeal of NVIV is MNKD's alfrezza. Ok, I pimped it. Gotta love winning solutions. IMO, NVIV is grossly undervalued going into may 2013. This stock, like many otc stocks, just hasn't had enough exposure to the general market. This will change quickly with uplisting and a road trip or two. Five and change is a reasonable short term number.